$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Is durvalumab a drug targeting PD-1 or PD-L1?
2026-02-01 22:25:32
Check Details
Is zotuximab already included in the scope of medical insurance reimbursement?
2026-02-01 22:25:32
Check Details
Can lorlatinib treat osimertinib-resistant lung cancer? Does it apply to EGFR mutations?
2026-02-01 22:25:32
Check Details
What diseases is pomalidomide used to treat? What are its indications?
2026-02-01 22:25:32
Check Details
What are the contraindications to the use of lapatinib? Who is not suitable for this drug?
2026-02-01 22:25:32
Check Details
Can filgotinib be used with other medicines? What should I pay attention to when using combined drugs?
2026-02-01 22:25:32
Check Details
Which patients is Lorlatinib mainly suitable for? Scope of application of targeted therapy and genetic testing requirements
2026-02-01 22:25:32
Check Details
How should fostatinib be taken? What is the correct usage and dosage?
2026-02-01 22:25:32
Check Details
What is the usage and dosage of bosutinib? What is the correct method and dosage of taking it?
2026-02-01 22:25:32
Check Details
Who is recommended to use Militizumab? What patient groups is it suitable for?
2026-02-01 22:25:32
Check Details
How long does it take for Lorlatinib to take effect? Clinical trial data and patient feedback
2026-02-01 22:25:32
Check Details
What drug is pomalidomide? What are its main ingredients and functions?
2026-02-01 22:25:32
Check Details
1
2
...
1499
1500
1501
1502
1503
1504
1505
...
10225
10226
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Midostaurin vs. Gilteritinib: Key Differences in FLT3-Targeted AML Therapy
2
Lapatinib: A Targeted Anticancer Agent — Not Merely Symptom Relief
3
Filgotinib: Mechanism of Action and Clinical Applications Explained
4
Lapatinib: Proper Administration Guide and Key Precautions
5
Capivasertib (Truqap) Complete Medication Guide: Indications, Dosing, Safety, and Precautions
6
Cemiplimab Storage and Handling Guide
7
ASCO 2026: Spevatamig Opens a New Path in Pancreatic Cancer Immunotherapy
8
FDA Approves First mRNA Flu Vaccine mFLUSIVA
9
Nintedanib Indications Explained: Beyond Idiopathic Pulmonary Fibrosis
10
How Long Does Belumosudil Take to Work for Pulmonary cGVHD?
11
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Dosing Duration, Efficacy Comparison, and Long-Term Management
12
Belzutifan (Welireg): Comprehensive Guide to the First HIF-2α Inhibitor — Indications, Dosing, and Safety Monitoring